Sylvie Radenne

6.0k total citations
41 papers, 981 citations indexed

About

Sylvie Radenne is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Sylvie Radenne has authored 41 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 29 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Sylvie Radenne's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (14 papers) and Hepatitis C virus research (13 papers). Sylvie Radenne is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (14 papers) and Hepatitis C virus research (13 papers). Sylvie Radenne collaborates with scholars based in France, United States and Switzerland. Sylvie Radenne's co-authors include Jérôme Dumortier, Christian Ducerf, Fabien Zoulim, J Baulieux, T Bizollon, Georges‐Philippe Pageaux, Christian Trépo, Olivier Guillaud, Vincent Leroy and C. Trépo and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Sylvie Radenne

37 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Radenne France 15 795 657 238 107 63 41 981
José Luís Lázaro Spain 13 527 0.7× 257 0.4× 392 1.6× 119 1.1× 43 0.7× 16 650
M Rela United Kingdom 14 304 0.4× 218 0.3× 304 1.3× 33 0.3× 31 0.5× 30 611
Ravi Mohanka India 18 369 0.5× 225 0.3× 436 1.8× 245 2.3× 35 0.6× 60 798
Jiayin Yang China 16 594 0.7× 238 0.4× 617 2.6× 71 0.7× 16 0.3× 93 789
Winnie Wong Canada 14 601 0.8× 454 0.7× 360 1.5× 122 1.1× 12 0.2× 22 896
C. Jiménez Romero Spain 15 374 0.5× 291 0.4× 405 1.7× 56 0.5× 14 0.2× 31 668
N Ahsan United States 12 305 0.4× 200 0.3× 306 1.3× 190 1.8× 112 1.8× 27 629
John P. Roberts United States 9 652 0.8× 487 0.7× 412 1.7× 91 0.9× 8 0.1× 12 840
A Rafecas Spain 13 468 0.6× 257 0.4× 426 1.8× 36 0.3× 10 0.2× 51 683
Jean‐Marc Cisterne France 12 366 0.5× 404 0.6× 265 1.1× 544 5.1× 68 1.1× 17 989

Countries citing papers authored by Sylvie Radenne

Since Specialization
Citations

This map shows the geographic impact of Sylvie Radenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Radenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Radenne more than expected).

Fields of papers citing papers by Sylvie Radenne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Radenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Radenne. The network helps show where Sylvie Radenne may publish in the future.

Co-authorship network of co-authors of Sylvie Radenne

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Radenne. A scholar is included among the top collaborators of Sylvie Radenne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Radenne. Sylvie Radenne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nkontchou, G., Louis d’Altéroche, Sylvie Radenne, et al.. (2024). The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience. Clinics and Research in Hepatology and Gastroenterology. 48(6). 102355–102355.
3.
Steiner, Alexandre A., Olivier Boillot, Mélanie Vallin, et al.. (2024). Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease. Clinical Transplantation. 38(11). e70014–e70014. 1 indexed citations
4.
Dumortier, Jérôme, Filoména Conti, Jean‐Baptiste Hiriart, et al.. (2023). Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study. Liver Transplantation. 29(12). 1313–1322. 7 indexed citations
5.
Lebossé, Fanny, Marie‐Laure Plissonnier, Jean‐Christophe Lega, et al.. (2023). Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis. iScience. 26(8). 107427–107427. 1 indexed citations
6.
Coilly, Audrey, Mylène Sebagh, Claire Fougerou‐Leurent, et al.. (2022). HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation. Clinics and Research in Hepatology and Gastroenterology. 46(9). 102024–102024.
7.
Altwegg, Romain, David Laharie, Victor de Lédinghen, et al.. (2018). Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series. Digestive and Liver Disease. 50(7). 668–674. 23 indexed citations
8.
Clifford, Gary M., Laurent Siproudhis, Lionel Piroth, et al.. (2018). Determinants of high-grade anal intraepithelial lesions in HIV-positive MSM. AIDS. 32(16). 2363–2371. 15 indexed citations
9.
Saliba, Faouzi, Lionel Rostaing, Jean Gugenheim, et al.. (2016). Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus. Transplantation. 100(8). 1705–1713. 13 indexed citations
11.
Souza, V. de, Aoumeur Hadj‐Aïssa, Muriel Rabilloud, et al.. (2013). Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis. Hepatology. 59(4). 1522–1531. 93 indexed citations
12.
Coilly, Audrey, Bruno Roche, Jérôme Dumortier, et al.. (2013). Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience. Journal of Hepatology. 60(1). 78–86. 142 indexed citations
14.
Saliba, Faouzi, Sébastien Dharancy, R. Lorho, et al.. (2011). Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis. Liver Transplantation. 17(8). 905–913. 61 indexed citations
15.
Kamar, Nassim, E. B. Haagsma, Valérie Garrigue, et al.. (2011). 129 PREDICTIVE FACTORS, NATURAL HISTORY AND OUTCOME OF CHRONIC HEPATITIS E VIRUS INFECTION IN SOLID-ORGAN-TRANSPLANT PATIENTS: A RETROSPECTIVE MULTICENTER STUDY. Journal of Hepatology. 54. S57–S57. 1 indexed citations
16.
Rognant, Nicolas, et al.. (2010). What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis?. Nephrology Dialysis Transplantation. 25(11). 3569–3575. 24 indexed citations
17.
Zoulim, Fabien, Sylvie Radenne, & Christian Ducerf. (2008). Management of patients with decompensated hepatitis B virus associated cirrhosis. Liver Transplantation. 14(S2). S1–S7. 22 indexed citations
18.
Bizollon, T, Pierre Pradat, Jean‐Yves Mabrut, et al.. (2005). Benefit of Sustained Virological Response to Combination Therapy on Graft Survival of Liver Transplanted Patients with Recurrent Chronic Hepatitis C. American Journal of Transplantation. 5(8). 1909–1913. 84 indexed citations
20.
Rabodonirina, Méja, Laurent Cotte, Sylvie Radenne, Emilio Besada, & Christian Trépo. (2003). Microsporidiosis and Transplantation: A Retrospective Study of 23 Cases. Journal of Eukaryotic Microbiology. 50(s1). 583–583. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026